Israel’s BrainStorm gets U.S. patent for stem cell technology | Reuters – Reuters
| Reuters Pending approval from the U.S. Food & Drug Administration, the company is preparing for its upcoming mid-stage Phase II trial in the United States with its NurOwn adult stem cell therapy. BrainStorm is developing NurOwn for the treatment of amyotrophic … Israel’s BrainStorm gets US patent for stem cell technologyYahoo News |
